Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.
Health Technol Assess
; 22(34): 1-280, 2018 06.
Article
in En
| MEDLINE
| ID: mdl-29900829
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Tumor Necrosis Factor-alpha
/
Antirheumatic Agents
Type of study:
Clinical_trials
/
Guideline
/
Health_technology_assessment
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Health Technol Assess
Journal subject:
PESQUISA EM SERVICOS DE SAUDE
/
TECNOLOGIA MEDICA
Year:
2018
Type:
Article
Affiliation country:
United kingdom